| UniProt ID | MAML1_HUMAN | |
|---|---|---|
| UniProt AC | Q92585 | |
| Protein Name | Mastermind-like protein 1 | |
| Gene Name | MAML1 {ECO:0000312|HGNC:HGNC:13632} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1016 | |
| Subcellular Localization | Nucleus speckle . Nuclear, in a punctate manner. | |
| Protein Description | Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Enhances phosphorylation and proteolytic turnover of the NOTCH intracellular domain in the nucleus through interaction with CDK8. Binds to CREBBP/CBP which promotes nucleosome acetylation at NOTCH enhancers and activates transcription. Induces phosphorylation and localization of CREBBP to nuclear foci. Plays a role in hematopoietic development by regulating NOTCH-mediated lymphoid cell fate decisions.. | |
| Protein Sequence | MVLPTCPMAEFALPRHSAVMERLRRRIELCRRHHSTCEARYEAVSPERLELERQHTFALHQRCIQAKAKRAGKHRQPPAATAPAPAAPAPRLDAADGPEHGRPATHLHDTVKRNLDSATSPQNGDQQNGYGDLFPGHKKTRREAPLGVAISSNGLPPASPLGQSDKPSGADALQSSGKHSLGLDSLNKKRLADSSLHLNGGSNPSESFPLSLNKELKQEPVEDLPCMITGTVGSISQSNLMPDLNLNEQEWKELIEELNRSVPDEDMKDLFNEDFEEKKDPESSGSATQTPLAQDINIKTEFSPAAFEQEQLGSPQVRAGSAGQTFLGPSSAPVSTDSPSLGGSQTLFHTSGQPRADNPSPNLMPASAQAQNAQRALAGVVLPSQGPGGASELSSAHQLQQIAAKQKREQMLQNPQQATPAPAPGQMSTWQQTGPSHSSLDVPYPMEKPASPSSYKQDFTNSKLLMMPSVNKSSPRPGGPYLQPSHVNLLSHQPPSNLNQNSANNQGSVLDYGNTKPLSHYKADCGQGSPGSGQSKPALMAYLPQQLSHISHEQNSLFLMKPKPGNMPFRSLVPPGQEQNPSSVPVQAQATSVGTQPPAVSVASSHNSSPYLSSQQQAAVMKQHQLLLDQQKQREQQQKHLQQQQFLQRQQHLLAEQEKQQFQRHLTRPPPQYQDPTQGSFPQQVGQFTGSSAAVPGMNTLGPSNSSCPRVFPQAGNLMPMGPGHASVSSLPTNSGQQDRGVAQFPGSQNMPQSSLYGMASGITQIVAQPPPQATNGHAHIPRQTNVGQNTSVSAAYGQNSLGSSGLSQQHNKGTLNPGLTKPPVPRVSPAMGGQNSSWQHQGMPNLSGQTPGNSNVSPFTAASSFHMQQQAHLKMSSPQFSQAVPNRPMAPMSSAAAVGSLLPPVSAQQRTSAPAPAPPPTAPQQGLPGLSPAGPELGAFSQSPASQMGGRAGLHCTQAYPVRTAGQELPFAYSGQPGGSGLSSVAGHTDLIDSLLKNRTSEEWMSDLDDLLGSQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 35 | Phosphorylation | ELCRRHHSTCEARYE HHHHHCCCHHHHHHH | 28.73 | - | |
| 41 | Phosphorylation | HSTCEARYEAVSPER CCHHHHHHHCCCHHH | 18.45 | 23403867 | |
| 45 | Phosphorylation | EARYEAVSPERLELE HHHHHCCCHHHHHHH | 28.26 | 19664994 | |
| 67 | Sumoylation | HQRCIQAKAKRAGKH HHHHHHHHHHHCCCC | 37.76 | - | |
| 75 | Methylation | AKRAGKHRQPPAATA HHHCCCCCCCCCCCC | 54.94 | 115482511 | |
| 112 | Acetylation | THLHDTVKRNLDSAT CCHHHHHHHHCCCCC | 37.35 | 25953088 | |
| 117 | Phosphorylation | TVKRNLDSATSPQNG HHHHHCCCCCCCCCC | 36.29 | 30624053 | |
| 119 | Phosphorylation | KRNLDSATSPQNGDQ HHHCCCCCCCCCCCC | 44.91 | 23927012 | |
| 120 | Phosphorylation | RNLDSATSPQNGDQQ HHCCCCCCCCCCCCC | 24.97 | 23401153 | |
| 130 | Phosphorylation | NGDQQNGYGDLFPGH CCCCCCCCCCCCCCC | 18.27 | 28634120 | |
| 138 | Acetylation | GDLFPGHKKTRREAP CCCCCCCCCCCCCCC | 62.85 | 17300219 | |
| 139 | Acetylation | DLFPGHKKTRREAPL CCCCCCCCCCCCCCC | 41.40 | 17300219 | |
| 140 | Phosphorylation | LFPGHKKTRREAPLG CCCCCCCCCCCCCCC | 39.50 | - | |
| 151 | Phosphorylation | APLGVAISSNGLPPA CCCCEEECCCCCCCC | 14.17 | 29255136 | |
| 152 | Phosphorylation | PLGVAISSNGLPPAS CCCEEECCCCCCCCC | 28.89 | 29255136 | |
| 159 | Phosphorylation | SNGLPPASPLGQSDK CCCCCCCCCCCCCCC | 26.82 | 29255136 | |
| 164 | Phosphorylation | PASPLGQSDKPSGAD CCCCCCCCCCCCHHH | 45.89 | 29255136 | |
| 166 | Acetylation | SPLGQSDKPSGADAL CCCCCCCCCCHHHHH | 46.46 | 26051181 | |
| 168 | Phosphorylation | LGQSDKPSGADALQS CCCCCCCCHHHHHHH | 52.97 | 29255136 | |
| 175 | Phosphorylation | SGADALQSSGKHSLG CHHHHHHHCCCCCCC | 41.74 | 29255136 | |
| 176 | Phosphorylation | GADALQSSGKHSLGL HHHHHHHCCCCCCCC | 38.61 | 29255136 | |
| 178 | Acetylation | DALQSSGKHSLGLDS HHHHHCCCCCCCCCC | 31.78 | 26051181 | |
| 185 | Phosphorylation | KHSLGLDSLNKKRLA CCCCCCCCCCCHHHC | 38.59 | 21712546 | |
| 188 | Ubiquitination | LGLDSLNKKRLADSS CCCCCCCCHHHCCCC | 44.56 | 19608861 | |
| 188 | Acetylation | LGLDSLNKKRLADSS CCCCCCCCHHHCCCC | 44.56 | 17300219 | |
| 189 | Acetylation | GLDSLNKKRLADSSL CCCCCCCHHHCCCCC | 52.12 | 17300219 | |
| 214 | Acetylation | SFPLSLNKELKQEPV CCCCCCCHHHHCCCC | 70.49 | 26051181 | |
| 217 | Sumoylation | LSLNKELKQEPVEDL CCCCHHHHCCCCCCC | 54.42 | - | |
| 217 | Sumoylation | LSLNKELKQEPVEDL CCCCHHHHCCCCCCC | 54.42 | - | |
| 261 | Phosphorylation | LIEELNRSVPDEDMK HHHHHHHCCCCHHHH | 36.61 | 22199227 | |
| 268 | Ubiquitination | SVPDEDMKDLFNEDF CCCCHHHHHHHCCCH | 64.70 | 29967540 | |
| 278 | Acetylation | FNEDFEEKKDPESSG HCCCHHHHCCCCCCC | 56.10 | 17300219 | |
| 279 | Acetylation | NEDFEEKKDPESSGS CCCHHHHCCCCCCCC | 80.11 | 17300219 | |
| 283 | Phosphorylation | EEKKDPESSGSATQT HHHCCCCCCCCCCCC | 45.44 | 25159151 | |
| 284 | Phosphorylation | EKKDPESSGSATQTP HHCCCCCCCCCCCCC | 34.80 | 25159151 | |
| 286 | Phosphorylation | KDPESSGSATQTPLA CCCCCCCCCCCCCHH | 30.05 | 25159151 | |
| 288 | Phosphorylation | PESSGSATQTPLAQD CCCCCCCCCCCHHHC | 34.37 | 25159151 | |
| 290 | Phosphorylation | SSGSATQTPLAQDIN CCCCCCCCCHHHCCC | 18.86 | 25159151 | |
| 299 | Sumoylation | LAQDINIKTEFSPAA HHHCCCCCCCCCHHH | 37.20 | - | |
| 299 | Sumoylation | LAQDINIKTEFSPAA HHHCCCCCCCCCHHH | 37.20 | - | |
| 300 | Phosphorylation | AQDINIKTEFSPAAF HHCCCCCCCCCHHHH | 38.17 | 29255136 | |
| 303 | Phosphorylation | INIKTEFSPAAFEQE CCCCCCCCHHHHHHH | 13.85 | 29255136 | |
| 314 | Phosphorylation | FEQEQLGSPQVRAGS HHHHHHCCCCCCCCC | 22.28 | 25159151 | |
| 321 | Phosphorylation | SPQVRAGSAGQTFLG CCCCCCCCCCCCCCC | 28.39 | 23401153 | |
| 325 | Phosphorylation | RAGSAGQTFLGPSSA CCCCCCCCCCCCCCC | 21.65 | 26074081 | |
| 330 | Phosphorylation | GQTFLGPSSAPVSTD CCCCCCCCCCCCCCC | 37.02 | 28450419 | |
| 331 | Phosphorylation | QTFLGPSSAPVSTDS CCCCCCCCCCCCCCC | 39.46 | 28450419 | |
| 335 | Phosphorylation | GPSSAPVSTDSPSLG CCCCCCCCCCCCCCC | 25.99 | 28450419 | |
| 336 | Phosphorylation | PSSAPVSTDSPSLGG CCCCCCCCCCCCCCC | 40.50 | 28450419 | |
| 338 | Phosphorylation | SAPVSTDSPSLGGSQ CCCCCCCCCCCCCCC | 19.24 | 28450419 | |
| 340 | Phosphorylation | PVSTDSPSLGGSQTL CCCCCCCCCCCCCEE | 43.53 | 28450419 | |
| 344 | Phosphorylation | DSPSLGGSQTLFHTS CCCCCCCCCEEEECC | 20.42 | 28450419 | |
| 346 | Phosphorylation | PSLGGSQTLFHTSGQ CCCCCCCEEEECCCC | 32.84 | 28450419 | |
| 350 | Phosphorylation | GSQTLFHTSGQPRAD CCCEEEECCCCCCCC | 27.50 | 28450419 | |
| 351 | Phosphorylation | SQTLFHTSGQPRADN CCEEEECCCCCCCCC | 27.19 | 28450419 | |
| 360 | Phosphorylation | QPRADNPSPNLMPAS CCCCCCCCCCCCCHH | 32.45 | 29255136 | |
| 367 | Phosphorylation | SPNLMPASAQAQNAQ CCCCCCHHHHHHHHH | 18.29 | 23403867 | |
| 405 | Acetylation | QLQQIAAKQKREQML HHHHHHHHHHHHHHH | 47.53 | 19608861 | |
| 407 | Acetylation | QQIAAKQKREQMLQN HHHHHHHHHHHHHHC | 58.14 | 25953088 | |
| 419 | Phosphorylation | LQNPQQATPAPAPGQ HHCHHHCCCCCCCCC | 18.69 | 23401153 | |
| 428 | Phosphorylation | APAPGQMSTWQQTGP CCCCCCCCCCCCCCC | 20.71 | 23401153 | |
| 429 | Phosphorylation | PAPGQMSTWQQTGPS CCCCCCCCCCCCCCC | 23.19 | 23401153 | |
| 433 | Phosphorylation | QMSTWQQTGPSHSSL CCCCCCCCCCCCCCC | 35.64 | 23401153 | |
| 444 | Phosphorylation | HSSLDVPYPMEKPAS CCCCCCCCCCCCCCC | 18.30 | 26074081 | |
| 451 | Phosphorylation | YPMEKPASPSSYKQD CCCCCCCCCCHHCCC | 33.57 | 25849741 | |
| 453 | Phosphorylation | MEKPASPSSYKQDFT CCCCCCCCHHCCCCC | 43.75 | 26074081 | |
| 454 | Phosphorylation | EKPASPSSYKQDFTN CCCCCCCHHCCCCCC | 39.47 | 26074081 | |
| 455 | Phosphorylation | KPASPSSYKQDFTNS CCCCCCHHCCCCCCC | 19.60 | 26074081 | |
| 463 | Acetylation | KQDFTNSKLLMMPSV CCCCCCCCEEECCCC | 47.94 | 25953088 | |
| 472 | Acetylation | LMMPSVNKSSPRPGG EECCCCCCCCCCCCC | 50.59 | 25953088 | |
| 516 | Acetylation | VLDYGNTKPLSHYKA CCCCCCCCCCCCCCC | 48.22 | 26051181 | |
| 529 | Phosphorylation | KADCGQGSPGSGQSK CCCCCCCCCCCCCCH | 20.42 | 25849741 | |
| 536 | Acetylation | SPGSGQSKPALMAYL CCCCCCCHHHHHHHC | 26.82 | 26051181 | |
| 632 | Ubiquitination | QLLLDQQKQREQQQK HHHHHHHHHHHHHHH | 45.77 | 29967540 | |
| 794 | O-linked_Glycosylation | VGQNTSVSAAYGQNS CCCCCCCHHHCCCCC | 13.62 | 30059200 | |
| 813 | Acetylation | GLSQQHNKGTLNPGL CCCCCCCCCCCCCCC | 51.66 | 26051181 | |
| 822 | Acetylation | TLNPGLTKPPVPRVS CCCCCCCCCCCCCCC | 52.98 | 19608861 | |
| 827 | Methylation | LTKPPVPRVSPAMGG CCCCCCCCCCCCCCC | 41.60 | 115482503 | |
| 965 | O-linked_Glycosylation | TQAYPVRTAGQELPF CEEEECCCCCCCCCE | 35.06 | 30059200 | |
| 995 | Phosphorylation | GHTDLIDSLLKNRTS CCHHHHHHHHCCCCC | 28.71 | 24719451 | |
| 1001 | Phosphorylation | DSLLKNRTSEEWMSD HHHHCCCCCHHHHHH | 50.30 | 26552605 | |
| 1002 | Phosphorylation | SLLKNRTSEEWMSDL HHHCCCCCHHHHHHH | 30.22 | 26552605 | |
| 1007 | Phosphorylation | RTSEEWMSDLDDLLG CCCHHHHHHHHHHHC | 35.77 | 26552605 | |
| 1015 | Phosphorylation | DLDDLLGSQ------ HHHHHHCCC------ | 32.46 | 26552605 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MAML1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MAML1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAML1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| EP300_HUMAN | EP300 | physical | 12391150 | |
| EP300_HUMAN | EP300 | physical | 12050117 | |
| CBP_HUMAN | CREBBP | physical | 12050117 | |
| NOTC1_HUMAN | NOTCH1 | physical | 11101851 | |
| NOTC2_HUMAN | NOTCH2 | physical | 11101851 | |
| NOTC4_HUMAN | NOTCH4 | physical | 11101851 | |
| NOTC3_HUMAN | NOTCH3 | physical | 11101851 | |
| HDAC9_HUMAN | HDAC9 | physical | 20203086 | |
| NOTC1_HUMAN | NOTCH1 | physical | 22100894 | |
| SUH_HUMAN | RBPJ | physical | 23022380 | |
| NOTC1_HUMAN | NOTCH1 | physical | 23022380 | |
| PHF8_HUMAN | PHF8 | physical | 23022380 | |
| SMCA4_HUMAN | SMARCA4 | physical | 23022380 | |
| PB1_HUMAN | PBRM1 | physical | 23022380 | |
| EP300_HUMAN | EP300 | physical | 15546612 | |
| CDK8_HUMAN | CDK8 | physical | 15546612 | |
| RND3_HUMAN | RND3 | physical | 26108681 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-822, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-314 AND SER-360, ANDMASS SPECTROMETRY. | |